912846-63-0

Basic information

• Product Name: 2,2,2-trifluoro-N-[2-(4-fluorophenyl)ethyl]acetamide
• Synonyms: 2,2,2-trifluoro-N-[2-(4-fluorophenyl)ethyl]acetamide
• CAS NO: 912846-63-0
• Molecular Weight: 235.181
• Mol File: 912846-63-0.mol
• Article Data: 7

Chemical Properties

• CAS DataBase Reference: 2,2,2-trifluoro-N-[2-(4-fluorophenyl)ethyl]acetamide(CAS DataBase Reference)
• NIST Chemistry Reference: 2,2,2-trifluoro-N-[2-(4-fluorophenyl)ethyl]acetamide(912846-63-0)
• EPA Substance Registry System: 2,2,2-trifluoro-N-[2-(4-fluorophenyl)ethyl]acetamide(912846-63-0)

Safety Data

• Hazardous Substances Data: 912846-63-0(Hazardous Substances Data)

Usage

Molecular weight

267.21 g/mol

Structure

Contains a trifluoromethyl group (CF3) and a 4-fluorophenyl ethyl side chain (F-C6H4-CH2-CH3) attached to an amide functional group (-CONH2)

Type

Fluorinated amide compound

Usage

Used in pharmaceutical research and development as an intermediate in the synthesis of fluorinated pharmaceuticals and agrochemicals

Properties

Unique properties, stability, and bioavailability

Medicinal applications

Ability to interact with biological systems, making it a valuable tool in drug discovery and development

Industry potential

Promising candidate for further research in the pharmaceutical industry

Upstream product

• 1583-88-6 4-fluoro-2-phenethylamine 
• 76-05-1 trifluoroacetic acid 
• 407-25-0 trifluoroacetic anhydride 

Downstream Products

• 406923-91-9 7-fluoro-1,2,3,4-tetrahydroisoquinoline 
• 912878-83-2 7-fluoro-6-nitro-1,2,3,4-tetrahydroisoquinoline 
• 1292286-15-7 C₂₆H₃₀FN₃O₅ 
• 1292286-18-0 C₂₇H₃₄FN₃O₅S 

Relevant articles and documents

2,4-disubstituted pyrimidine derivative as well as preparation method and application thereof

The invention belongs to the field of chemical medicines, and particularly relates to a 2,4-disubstituted pyrimidine derivative as well as a preparation method and application thereof. The invention provides the 2,4-disubstituted pyrimidine derivative, wh

ALK KINASE INHIBITOR, AND PREPARATION METHOD AND USE THEREOF

An ALK kinase inhibitor compound as represented by Formula I, pharmaceutical composition containing the compound, and preparation method and use thereof in the preparation of drugs serving as an ALK inhibitor for treating cancer.

The discovery of potent and long-acting oral factor Xa inhibitors with tetrahydroisoquinoline and benzazepine P4 motifs

The discovery and evaluation of potent and long-acting oral sulfonamidopyrrolidin-2-one factor Xa inhibitors with tetrahydroisoquinoline and benzazepine P4 motifs are described. Unexpected selectivity issues versus tissue plasminogen activator in the form